High Seroprevalence of Enterovirus Infections in Apes and Old World Monkeys by Harvala, H et al.
High 
Seroprevalence 
of Enterovirus 
Infections in Apes 
and Old World 
Monkeys
Heli Harvala, Chloe L. McIntyre, Natsuko Imai, 
Lucy Clasper, Cyrille F. Djoko, Matthew LeBreton, 
Marion Vermeulen, Andrew Saville, 
Francisca Mutapi, Ubald Tamoufé, John Kiyang, 
Tafon G. Biblia, Nicholas Midzi, Takafi ra Mduluza, 
Jacques Pépin, Richard Njoum, Teemu Smura, 
Joseph N. Fair, Nathan D. Wolfe, Merja Roivainen, 
and Peter Simmonds
To estimate population exposure of apes and Old World 
monkeys in Africa to enteroviruses (EVs), we conducted a 
seroepidemiologic study of serotype-specifi c neutralizing 
antibodies against 3 EV types. Detection of species A, B, 
and D EVs infecting wild chimpanzees demonstrates their 
potential widespread circulation in primates. 
Enteroviruses (EVs) form a diverse genus in the virus family Picornaviridae. EVs that infect humans are 
divided genetically into 4 species (EV A–D), and each 
contains numerous antigenically distinct serotypes (1). 
Although EVs were originally classifi ed by serologic 
analysis and pathogenic properties in laboratory animals, 
sequences from the viral capsid region provide an 
alternative method for classifi cation (2). More recently, 
classifi ed variants have been assigned as chronologically 
numbered EV types (currently to EV-C116).
EVs also naturally infect other mammalian species, 
although most are in separate species from those that infect 
humans. However, EVs isolated from Old World monkeys 
(OWMs) (principally Asian macaques) are grouped into 
species A and B; a separate simian species (SEV-A); or are 
unassigned (EV-108, SV6, and EV-103) (3).
Although EV isolates from OWMs have been 
extensively characterized, little attention has been paid 
to EVs that circulate in apes. We recently detected EV-
A76 (species A) and a new EV type in species B and D 
(EV-B110 and EV-D111) that infect a wild population 
of chimpanzees (Pan troglodytes) in Cameroon (3). 
Detection frequencies of 15% in fecal samples suggest that 
EV infections are relatively common in this species. We 
estimated population exposure of apes in Africa and OWM 
species to EVs.
The Study
To estimate population exposure of apes and OWM 
species in Africa to EVs, we conducted a seroepidemiologic 
study of serotype-specifi c neutralizing antibodies against 
3 EV types. These seroprevalences were compared with 
seroprevalences in human populations in areas where 
primates also lived (Cameroon, Zimbabwe, and South 
Africa) and with those in control populations in Europe 
(United Kingdom and Finland). Ethical approval for the 
use of study samples was obtained from the University of 
Zimbabwe Institutional Review Board and the Medical 
Research Council of Zimbabwe; the Human Research 
Ethics Committee, South African National Blood Service; 
the ethics committees of the Cameroonian Ministry of 
Health; the Centre Hospitalier Universitaire de Sherbrooke, 
Canada; and Lothian Regional Ethics Committee, 
Edinburgh.
EV-D94 (E210), EV-A76 (KAZ00–14550) (4,5), and 
a clinical isolate of echovirus 11 from Edinburgh (E-11) 
were used for seroprevalence studies. Neutralization assays 
were performed in human rhabdomyosarcoma cells as 
described (6) with 1 minor change (inactivation at 56°C for 
45 min). Serum specimens at 2 dilutions (1:16 and 1:64) 
were incubated with virus (one hundred 50% tissue culture 
infectious doses) in 96-well plates. Rhabdomyosarcoma 
cells were added to wells (≈2 × 105 cells/mL), and cultures 
were incubated at 37°C for <6 days. The highest dilution 
that completely inhibited viral replication was taken as the 
endpoint titer for the sample.
Plasma samples were collected from chimpanzees 
(P. troglodytes), gorillas (Gorilla gorilla gorilla), and 
several OWMs (Table 1). Sample shipments complied 
with the Convention on International Trade in Endangered 
Species of Wild Fauna and Flora. Samples were collected 
for veterinary welfare purposes from animals in 2 wildlife 
sanctuaries in Yaoundé and Limbe, Cameroon. Animals 
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were primarily wild born and brought to sanctuaries after 
confi scation by authorities or abandonment by owners. 
Human samples were obtained from 3 sub-Saharan African 
populations and control groups in the United Kingdom and 
Finland (Table 2). None had identifi able compounding risk 
factors that infl uenced their exposure to EVs. Plasma was 
separated from anticoagulated blood by centrifugation and 
stored at −70°C until testing.
The study was designed to determine the extent to which 
a human EV serotype (E-11) could spread into nonhuman 
populations, and conversely, the extent to which EV-A76 
(previously recovered from chimpanzees) circulated in 
human populations in areas where chimpanzees also lived 
(Cameroon), elsewhere in Africa in regions without apes, 
and in nonprimate-exposed control populations in Europe. 
Species D viruses are frequently isolated from chimpanzees 
and gorillas (3), and we selected EV-D94, isolated from 
populations in central Africa, as a representative of this 
species.
Chimpanzees and gorillas showed evidence (Figure) 
of extensive previous exposure to E-11 (58% and 72%) 
and EV-A76 (40% and 11%). Lower levels of antibodies 
were detected against EV-D94 (13% and 0%). Conversely, 
OWMs showed higher seroreactivity with EV-A76 
(37%) than with E-11 (15%) and EV-D94 (2%), which 
demonstrated wide circulation of this virus among OWM 
species. Seven samples from mona monkeys accounted 
for half of E-11–positive samples, and EV-A76 antibodies 
were widely distributed in baboons, mandrills, and other 
species.
Contrasting patterns of EV exposure to the 3 EV types 
were observed in humans (Figure). High seroprevalences of 
E-11 and EV-D94 were observed in all human populations 
(53%–95% and 63%–85%), whereas seroreactivity to 
EV-A76 was largely confi ned to Cameroon (55%) and 
Zimbabwe (35%), and uniformly <6% elsewhere.
Conclusions
Serologic testing of nonhuman primate samples 
provided unequivocal evidence of exposure to all 3 
serotypes. Although primate sampling was restricted to 
animals held in sanctuaries under veterinary supervision 
and infections may have been acquired in captivity from 
human or dietary sources, epidemiologic observations 
support the hypothesis that EV infections may also be 
acquired in the wild. Many sampled animals were adults on 
entry to sanctuaries, while analogous to human infections, 
and EV exposure is frequent during infancy or childhood. 
Also, EV infections in apes are widespread in the wild, 
and active infections are found in more than one sixth of 
animals screened (3).
Another factor determining whether EVs can be 
indigenous to a species or originate from repeated 
external (cross-species) transmission is host population 
size. Perpetuation of nonpersistent viruses requires 
minimum population sizes large enough to sustain 
chains of transmission, which is dependent on duration 
of infectivity, seasonality of infections, duration of 
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Table 1. Seroprevalence of echovirus and enterovirus among apes and Old World monkeys, sub-Saharan Africa and Europe 
Taxonomic name (common name) No. tested Date 
No. (%) positive  
Echovirus 11 Enterovirus A76 Enterovirus D94 
Apes      
 Pan troglodytes (chimpanzee) 40 2005–2009 23 (57.5) 16 (40.0) 5 (12.5) 
 Gorilla gorilla gorilla (gorilla) 9 2004–2008 8 (72.0) 1 (11.0) 0 
 Total 49 2004–2009 31 (63.0) 17 (35.0) 5 (10.0) 
Old World Monkeys      
 Genus Cercopithecus      
  C. erythrotis (red-eared monkey) 3 2007–2008 0 0 0 
  C. preussi (Preussi’s monkey) 3 2007–2009 0 1 (33.0) 0 
  C. pogonias (crowned monkey) 1 2009 0 0 0 
  C. mona (mona monkey) 7 2006–2009 4 (57.0) 1 (14.0) 0 
  C. nictitans (spot-nosed monkey) 3 2007–2009 0 0 0 
 Genus Madrillus      
  M. sphinx (mandrill) 5 2006–2009 1 (20.0) 3 (60.0) 0 
  M. leucophaeus (drill) 16 2006–2009 3 (18.8) 5 (28.0) 1 (6.0) 
 Genus Chlorocebus      
  C. tantalus (tantalus monkey) 1 2007 0 1 (100.0) 0 
 Genus Erythrocebus      
  E. patas (patas monkey) 2 2008 0 2 (100.0) 0 
 Genus Papio      
  P. anubis (olive baboon) 19 2006–2009 1 (5.3) 9 (47.0) 0 
 Total 60 2006–2009 9 (15.0) 22 (37.0) 1 (2.0) 
Table 2. Human samples from sub-Saharan Africa and Europe 
tested for echovirus and enterovirus antibodies* 
Country Category Mean age, y Year 
Cameroon General population >60 2007 
Zimbabwe General population 45 2007 
South Africa Blood donors 25 2009 
Finland Pregnant women 30 2002 
UK General population 55 2009 
*Forty samples from each country were used.  
Enterovirus in Apes and Old World Monkeys
immunity, generation time of the virus and host, rate of 
population turnover (7,8), and degree of fragmentation 
of populations. These parameters are diffi cult to estimate 
in nonhuman primates, although studies of isolated 
human communities show that population size needed 
for maintaining transmission of EVs may be large, e.g., 
poliovirus infections were not sustained among an Eskimo 
community of 450 persons (9). Therefore, chimpanzee 
and gorilla populations may be too small and fragmented 
to sustain EV infections. However, relatively long-term 
fecal excretion of EVs, the environmental stability of 
shed EVs, and contamination of nest sites may perpetuate 
infections within an established group.
In contrast to apes, the population size of several OWM 
species is large and with higher population connectivity, 
turnover, and supply of susceptible animals, may support 
indigenous circulation of EVs. Supporting this suggestion 
is genetic evidence that EVs isolated from OWMs in 
southern Asia and Africa group separately from most 
variants identifi ed in humans elsewhere by phylogenetic 
analysis (10). EV variants in chimpanzees that matched 
OWM serotypes (e.g., EV-B110 most closely related to 
SA5, and EV-A76, EV-A89, and EV-A90 in the OWM 
species A group) (3; unpub. data) suggest that OWMs 
are a potential source of infection. Predation of the red 
colobus monkey by chimpanzees (11,12) may favor such 
cross-species transmissions, as documented in the genesis 
of simian immunodefi ciency virusCPZ from OWM simian 
immunodefi ciency viruses (13). Cross-species transmission 
from OWMs to apes is consistent with high seroprevalences 
of EV-A76 antibodies in apes, baboons, and other OWMs.
Overall, our serologic survey data and previous 
fecal sampling data (3) provide evidence for extensive 
circulation of EVs between primates and existence of 
human and OWM reservoirs of infection that may spill 
over into ape populations too small to maintain indigenous 
EV variants. Whether OWMs or apes represent a potential 
source of new EVs in humans (that may become pandemic 
in the absence of prior population exposure) is uncertain. 
However, the global outbreak of EV-D70 that originally 
centered on a cluster of human infections in central Africa 
(14,15) provides a potential example of this occurrence. 
Extensive past infection of a variety of EVs in apes and 
OWMs should lead to a reappraisal of the host range of 
what have been considered to be primarily human viruses 
and a potential source for the periodic emergence of new 
EV types into immunologically naive human populations.
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Figure. Seroprevalence of neutralizing antibody (titers >16) to 
echovirus 11 (E-11) and enteroviruses A76 (EV-A76) and D94 (EV-
D94) in A) human populations and B) nonhuman primates.
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